Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
110 participants
INTERVENTIONAL
2012-06-01
2013-11-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Home-based Vision Therapy
NCT06886737
Eyetracking and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury
NCT03319966
Improving Visual Field Deficits With Noninvasive Brain Stimulation
NCT05085210
Effect of Visual Retraining After Stroke
NCT06121219
Study on the Effectiveness and Safety of VRT in Patients With Visual Field Defects
NCT06914505
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1
Group 1 - Combination Treatment
Vision Restoration Therapy
Therapy that enhances the neuronal plasticity of the visual system
NVT Eye Scanning Therapy
Therapy that trains eye and head scanning into the blind hemianoptic visual field
Arm 2
Group 2 - Combination Treatment
Eccentric Viewing Training
Therapy that trains the person to compensate for visual field loss by learning to move the visual field loss to the position that is least likely to impact the current visual task
Arm 3
Group 3 - Combination Treatment
Vision Restoration Therapy
Therapy that enhances the neuronal plasticity of the visual system
NVT Eye Scanning Therapy
Therapy that trains eye and head scanning into the blind hemianoptic visual field
Arm 4
Group 4 - Combination Treatment
Eccentric Viewing Training
Therapy that trains the person to compensate for visual field loss by learning to move the visual field loss to the position that is least likely to impact the current visual task
Arm 5
Group 5 - Monotherapy Treatment
Vision Restoration Therapy
Therapy that enhances the neuronal plasticity of the visual system
Sham
Therapy that encourages subjects to do daily visual tasks at home while having no training or intended intervention benefit
Arm 6
Group 6 - Monotherapy Treatment
Eccentric Viewing Training
Therapy that trains the person to compensate for visual field loss by learning to move the visual field loss to the position that is least likely to impact the current visual task
Sham
Therapy that encourages subjects to do daily visual tasks at home while having no training or intended intervention benefit
Arm 7
Group 7 - Monotherapy Treatment
NVT Eye Scanning Therapy
Therapy that trains eye and head scanning into the blind hemianoptic visual field
Sham
Therapy that encourages subjects to do daily visual tasks at home while having no training or intended intervention benefit
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vision Restoration Therapy
Therapy that enhances the neuronal plasticity of the visual system
NVT Eye Scanning Therapy
Therapy that trains eye and head scanning into the blind hemianoptic visual field
Eccentric Viewing Training
Therapy that trains the person to compensate for visual field loss by learning to move the visual field loss to the position that is least likely to impact the current visual task
Sham
Therapy that encourages subjects to do daily visual tasks at home while having no training or intended intervention benefit
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hemianopic Visual Field Loss
* Stable fixation
* 1.0 logMAR or better Reading Acuity
* 20 words per minute or better reading rate
Exclusion Criteria
* medical conditions that prevent sitting for 30 minutes or following instructions
20 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ron Schuchard, PhD
Role: PRINCIPAL_INVESTIGATOR
VA Palo Alto Health Care System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Palo Alto Health Care System
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C6687-R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.